Promising breast cancer drug study halted early
NCT ID NCT05085002
First seen May 16, 2026 · Last updated May 16, 2026
Summary
This study tested a new drug called lerociclib combined with standard hormone therapy for people with a certain type of advanced breast cancer (HR+/HER2-). It aimed to see if the combination was safe and effective for those newly diagnosed or whose cancer had worsened after initial treatment. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ARENSIA Exploratory Medicine LLC
Tbilisi, 0112, Georgia
-
CHA Libramont
Libramont, 6800, Belgium
-
Cancer Care Associates of York, Inc.
York, Pennsylvania, 17403, United States
-
Cancer Specialists of North Florida
Jacksonville, Florida, 32256, United States
-
Clinique Saint-Pierre asbl
Ottignies, 1340, Belgium
-
IMSP Institutul Oncologic, Arsenia Exploratory Medicine
Chisinau, MD-2025, Moldova
-
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
Meldola, 47014, Italy
-
LTD "Brothers"
Batumi, 6010, Georgia
-
LTD "Health House"
Tbilisi, 0144, Georgia
-
Ltd "Multiprofile Clinic Consilium Medulla "
Tbilisi, 0186, Georgia
-
Ltd Israeli-Georgian Medical Research Clinic Helsicore
Tbilisi, 0112, Georgia
-
Nebraska Cancer Specialists
Omaha, Nebraska, 68130, United States
-
Northwest Medical Specialties PLLC
Tacoma, Washington, 98405, United States
-
Oregon Oncology Specialists
Salem, Oregon, 97301, United States
-
PanAmerican Clinical Research Cuernavaca
Cuernavaca, 66290, Mexico
-
PanAmerican Clinical Research Guadalajara
Guadalajara, Jalisco, 44670, Mexico
-
PanAmerican Clinical Research, Queretaro
Querétaro, 76100, Mexico
-
Tranquil Clinical Research
Webster, Texas, 16969, United States
-
UZA
Edegem, 2650, Belgium
-
Ziekenhuizen K.U.Leuven, Campus gasthuisberg
Leuven, 3000, Belgium
-
vzw Verenigde Ziekenhuizen van Waas en Durme - VITAZ
Sint-Niklaas, 9100, Belgium
Conditions
Explore the condition pages connected to this study.